Access to medicines and treatment
Bangkok Post | 4 hours ago
The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.
IRMA | 4 hours ago
IRMA applauds the launch of the world’s first-ever Phase II rectal microbicide trial. The Microbicide Trial Network’s study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally. Volunteers consisting of gay men, other men who have sex with men, and transgender women will participate in the study at sites in the United States and in Thailand, South Africa, and Peru.
Aidspan | 4 hours ago
Morocco's human rights landscape is evolving for a number of reasons, many of which could have a positive effect on the way the country responds to its HIV epidemic. The right to access health services, the right to respect for human dignity, the right to discretion and privacy: all are becoming normative in the traditionally conservative Kingdom, which was among the only countries in the region that did not experience any upheaval during the Arab Spring.
Treatment for women
Health Affairs (blog) | 4 hours ago
A global health controversy erupted this summer when the prominent scientific journal Nature ran an article entitled “HIV trial attacked.” Within, commentators squared off over whether a huge ongoing study provides suboptimal and thus unethical treatment options to mothers with HIV in the developing world.
The search for a cure
Treatment Action Group | 4 hours ago
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.
BBC World Have Your Say (audio) | 21 hours ago
BBC World Service phone-in discussion on pre-exposure prophylaxis (PrEP). Contributors include Michael Weinstein (AIDS Healthcare Foundation), Helen Rees (Wits Reproductive Health and HIV Institute), Garry Brough (Terrence Higgins Trust), David Campos (San Francisco Board of Supervisors) and PrEP users.
TheBody.com | 01 October 2014
"On good days, adhering to my pill is a positive affirmation of my life, an exercise in self-love. On bad days, it's just a pill I need to swallow, not terribly bitter but as mildly annoying as having to shave or tie my shoelaces every day. It's yet another thing to add to my list of things, but I do it anyway." Josh Kruger on his ambiguous relationship to HIV treatment.
Religion and faith
Faith Action | 01 October 2014
As a network of faith-based organisations, FaithAction knows that there are many faith groups up and down the country doing health-related work in their communities. However, the value of this work is in danger of not being recognised, both by the groups themselves and by policymakers, in large part because there is a lack of evidence around what is taking place and its effectiveness.
BMJ Group blogs | 01 October 2014
A recently published study claims to provide the first whole population analysis of the impact on genital warts of a national HPV vaccination programme – and this may be the best predictor of the longer-term, and more important, cancer prevention benefits to be seen in future years. The findings show a decline of 89.9% in admissions involving warts from 2006/7 to 2010/11 for girls aged 12-17 yrs, a decline of 72.7% for women aged 18-26, and a decline of 38% for men aged 18-14 (the indirect effect of female vaccination).
Health-e | 01 October 2014
After almost two decades spent fighting for HIV treatment and access to medicines, the Treatment Action Campaign (TAC) may close its doors due to a severe funding shortage.